A rapid rise in the rate of oropharyngeal cancer among men is being linked to human papillomavirus (HPV), and the number of cases in the

Beginning September 2012, the U.S. Food and Drug Administration (FDA) will require larger, more prominent cigarette health warnings on all cigarette packaging and advertisements in

African-Americans have fewer incidences of thyroid cancer but have a more advanced form of the disease once they receive a diagnosis and are more likely

Patients’ concerns about appearance following treatment of oral and oropharyngeal cancer and the impact this has on their quality of life are critical factors for

Researchers from the Duke Cancer Institute and the University of Chicago have found a way to identify patients with recurring head and neck cancer who

OralDNA Labs has appointed Ken Clarke as general manager, the company announced. Clarke will report to Dermot Shorten, vice president, office of the chairman, and

NEW YORK (Reuters Health) – Palifermin (Kepivance) helps reduce the rate, severity, and duration of severe oral mucositis in head and neck cancer patients receiving

Pharmaceutical company CEL-SCI has begun phase III clinical trials for its immunotherapy drug Multikine in Hungary. Studies are already ongoing at 12 clinical sites in

An Illinois man who underwent surgery to remove a salivary gland tumor is suing the hospital where the procedure was done, the surgeon who performed